Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 12 de 12
Filtrar
1.
AANA J ; 81(3): 193-8, 2013 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-23923669

RESUMO

The purpose of this study was to investigate the anxiolytic effects of xanthohumol, a component of Humulus lupulus (hops), and its potential interaction with the benzodiazepine binding site on the y-aminobutyric acid (GABAA) receptor in the male Sprague-Dawley rat. This was a prospective, randomized, between-subjects experimental study. Fifty-five rats were assigned to 1 Sof 5 groups with 11 rats per group: control (vehicle), xanthohumol, midazolam, midazolam with xanthohumol, and flumazenil with xanthohumol. In this study the elevated plus maze measured the behavioral components of anxiety and motor movements. A 2-tailed multivariate analysis of variance and least significant difference post hoc test was used to determine if a significant difference existed. Our data suggest that xanthohumol does not produce anxiolysis by modulation of the GABAA receptor; however, there may be a possible interaction between xanthohumol and midazolam, or xanthohumol may influence the modulation of another neurotransmitter site in the central nervous system. Alone, xanthohumol does not show significant modulation of the benzodiazepine receptor. Additional research should investigate if xanthohumol acts as a benzodiazepine GABAA partial agonist or antagonist or if it modulates another neurotransmitter system in the central nervous system.


Assuntos
Ansiolíticos/farmacologia , Flavonoides/farmacologia , Humulus , Aprendizagem em Labirinto/efeitos dos fármacos , Propiofenonas/farmacologia , Receptores de GABA-A/fisiologia , Animais , Masculino , Ratos , Ratos Sprague-Dawley
2.
Holist Nurs Pract ; 26(1): 52-7, 2012.
Artigo em Inglês | MEDLINE | ID: mdl-22157509

RESUMO

This was a prospective, randomized, between-subjects experimental study to investigate the anxiolytic effects of naringenin, a component of mentha aquatica, and its potential interaction with the benzodiazepine binding site on the γ-aminobutyric acid (GABAA) receptor in the rat. Fifty-five rats were assigned to one of 5 groups with 11 rats per group: control, naringenin, midazolam, midazolam with naringenin, and flumazenil with naringenin. The elevated plus maze measured the behavioral components of anxiety and motor movements. Our data suggest that naringenin does not produce anxiolysis by modulation of the GABAA receptor; however, the findings indicate that naringenin decreases motor movements (P < .05).


Assuntos
Ansiolíticos/uso terapêutico , Ansiedade/tratamento farmacológico , Flavanonas/uso terapêutico , Mentha/química , Atividade Motora/efeitos dos fármacos , Fitoterapia , Extratos Vegetais/uso terapêutico , Animais , Ansiolíticos/farmacologia , Comportamento Animal/efeitos dos fármacos , Benzodiazepinas/metabolismo , Sítios de Ligação , Flavanonas/farmacologia , Interações Ervas-Drogas , Masculino , Aprendizagem em Labirinto/efeitos dos fármacos , Extratos Vegetais/farmacologia , Estudos Prospectivos , Distribuição Aleatória , Ratos , Ratos Sprague-Dawley , Receptores de GABA-A/metabolismo , Ácido gama-Aminobutírico/metabolismo
3.
AANA J ; 79(2): 109-14, 2011 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-21560973

RESUMO

The purpose of this study was to investigate the anxiolytic effects of myristicin, a major compound found in nutmeg, and its potential interaction with the gamma-aminobutyric acid (GABA(A)) receptor in male Sprague-Dawley rats. Nutmeg has traditionally been used as a spice in food preparation and as an herbal remedy in the treatment of many medical conditions, including anxiety. Fifty-five rats were divided equally into 5 groups: control (vehicle); myristicin; midazolam (positive control); flumazenil and myristicin; and midazolam and myristicin. The behavioral component of anxiety was examined by using the elevated plus-maze (open-arm and closed-arm times) along with analysis of gross and fine motor movements. Data analysis was performed using a 2-tailed multivariate analysis of variance (MANOVA) and least significant difference post-hoc test. Our data suggest that myristicin does not decrease anxiety by modulation of the GABA(A) receptor but may promote anxiogenesis. When myristicin was combined with midazolam, an antagonist-like effect similar to the flumazenil and myristicin combination was exhibited by a decrease in anxiolysis compared with the midazolam-only group. Myristicin may antagonize the anxiolytic effects of midazolam, increase anxiety, and affect motor movements.


Assuntos
Ansiolíticos/farmacologia , Ansiedade/tratamento farmacológico , Compostos de Benzil/farmacologia , Dioxolanos/farmacologia , Aprendizagem em Labirinto/efeitos dos fármacos , Myristica/química , Pirogalol/análogos & derivados , Derivados de Alilbenzenos , Animais , Avaliação Pré-Clínica de Medicamentos , Flumazenil/farmacologia , Moduladores GABAérgicos/farmacologia , Masculino , Midazolam/farmacologia , Enfermeiros Anestesistas , Pirogalol/farmacologia , Ratos
4.
AANA J ; 79(4 Suppl): S75-80, 2011 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-22403971

RESUMO

The purpose of this study was to investigate the anxiolytic effects of tetrahydropalmatine (THP) and its potential interaction with the benzodiazepine binding site on the gamma-aminobutyric acid (GABAA) receptor in the male Sprague-Dawley rat. Tetrahydropalmatine (THP), an active component isolated from the Chinese herbal plant Corydalis yanhusuo, is used in Asia for its analgesic, sedative, and hypnotic properties during herbal therapy. Fifty-five rats were assigned to 1 of 5 groups with 11 rats per group: 1) control (vehicle), 2) THP, 3) midazolam, 4) midazolam with THP, and 5) flumazenil with THP. In this study, the elevated plus-maze measured the behavioral components of anxiety and motor movements. The data were analyzed using a 2-tailed multivariate analysis of variance to determine if a significant difference existed followed by the least significant difference post hoc test. The findings suggest that THP, 25 mg/kg, given via intraperitoneal injection, results in significant anxiolysis and decreased motor movements. Furthermore, flumazenil, 3 mg/kg, does not fully antagonize the effects of THP.


Assuntos
Ansiolíticos/farmacologia , Corydalis , Medicamentos de Ervas Chinesas/farmacologia , Moduladores GABAérgicos/farmacologia , Fitoterapia , Animais , Ansiolíticos/administração & dosagem , Quimioterapia Combinada , Medicamentos de Ervas Chinesas/administração & dosagem , Flumazenil/administração & dosagem , Flumazenil/farmacologia , Moduladores GABAérgicos/administração & dosagem , Masculino , Aprendizagem em Labirinto/efeitos dos fármacos , Midazolam/administração & dosagem , Midazolam/farmacologia , Destreza Motora/efeitos dos fármacos , Análise Multivariada , Estudos Prospectivos , Ratos , Ratos Sprague-Dawley
5.
AANA J ; 77(1): 33-6, 2009 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-19263826

RESUMO

The purpose of this study was to investigate the anxiolytic effects of luteolin and its potential interaction with the gamma-aminobutyric acid (GABAA) receptor in male Sprague-Dawley rats. Lemon balm has traditionally been used as an herbal remedy in the treatment of many medical conditions, including anxiety. Luteolin is a major component of the essential oil lemon balm. We divided 55 rats into 5 groups: (1) control (negative control), (2) luteolin, (3) midazolam (positive control), (4) flumazenil and luteolin, and (5) midazolam and luteolin. The behavioral component of anxiety was examined by using the elevated plus-maze (open arm time/total time) and motor movements. Data analyses were performed using a 2-tailed multivariate analysis of variance and Sheffé post hoc test. Our data suggest that luteolin does not produce anxiolysis by modulation of the GABAA receptor; however, luteolin may modulate motor movements and locomotion.


Assuntos
Ansiolíticos/farmacologia , Ansiedade/prevenção & controle , Luteolina/farmacologia , Receptores de GABA-A/efeitos dos fármacos , Animais , Ansiolíticos/uso terapêutico , Quimioterapia Combinada , Flumazenil/administração & dosagem , Flumazenil/farmacologia , Flumazenil/uso terapêutico , Moduladores GABAérgicos/administração & dosagem , Moduladores GABAérgicos/farmacologia , Moduladores GABAérgicos/uso terapêutico , Luteolina/uso terapêutico , Masculino , Midazolam/administração & dosagem , Midazolam/farmacologia , Midazolam/uso terapêutico , Análise Multivariada , Ratos , Ratos Sprague-Dawley
6.
AANA J ; 77(6): 445-9, 2009 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-20108732

RESUMO

The purpose of the study was to investigate the anxiolytic effects of L-theanine and its potential interaction with the GABAA receptor in Sprague-Dawley rats. L-theanine is a major component of green tea, which has traditionally been used as an herbal remedy in the treatment of many medical conditions, including anxiety. Herbals and supplements and their potential interactions perioperatively are a concern to anesthetists. Fifty-five rats were divided into 5 groups: control (saline); L-theanine (positive control); flumazenil (a known benzodiazepine receptor antagonist) and L-theanine; and midazolam and L-theanine. The behavioral component of anxiety was evaluated using the elevated plus-maze and calculated by the time spent in the open arm of the maze divided by total time in the maze. Data were analyzed using a 2-tailed multivariate analysis of variance and Sheffé posthoc test. The data suggest that L-theanine does not produce anxiolysis by modulation of the GABAA receptor; however, in combination with midazolam, a synergistic or additive effect was demonstrated by decreased anxiety and both fine and basic motor movements. These data may provide direction for further studies examining L-theanine and its effects on anxiety and motor activity.


Assuntos
Ansiolíticos/farmacologia , Ansiedade/tratamento farmacológico , Camellia sinensis/química , Sinergismo Farmacológico , Glutamatos/farmacologia , Midazolam/farmacologia , Fitoterapia , Extratos Vegetais/farmacologia , Animais , Masculino , Aprendizagem em Labirinto/efeitos dos fármacos , Análise Multivariada , Distribuição Aleatória , Ratos , Ratos Sprague-Dawley , Receptores de GABA-A/efeitos dos fármacos
7.
AANA J ; 76(1): 47-52, 2008 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-18323320

RESUMO

The purpose of our study was to investigate the anxiolytic effects of linalool and its potential interaction with the GABAA receptor in Sprague-Dawley rats. Lavender has been used traditionally as an herbal remedy in the treatment of many medical conditions, including anxiety. Linalool is a major component of the essential oil of lavender. Forty-four rats were divided into 4 groups: control, linalool, midazolam (positive control), and flumazenil and linalool. The behavioral and the neurohormonal/physiological components of anxiety were evaluated. The behavioral component was examined by using the elevated plus maze (open arm time/total time) and the neurohormonal/physiological component by measuring serum catecholamine and corticosterone levels. Data analysis was performed using a 2-tailed Multivariate Analysis of Variance and Sheffe post-hoc test. Our data suggest that linalool does not produce anxiolysis by modulation of the GABAA receptor; however, linalool may modulate motor movements and locomotion.


Assuntos
Ansiolíticos/uso terapêutico , Ansiedade/tratamento farmacológico , Lavandula , Monoterpenos/uso terapêutico , Fitoterapia/métodos , Extratos Vegetais/uso terapêutico , Monoterpenos Acíclicos , Animais , Ansiolíticos/farmacologia , Antídotos/uso terapêutico , Ansiedade/sangue , Ansiedade/psicologia , Comportamento Animal/efeitos dos fármacos , Modelos Animais de Doenças , Avaliação Pré-Clínica de Medicamentos , Epinefrina/sangue , Flumazenil/uso terapêutico , Moduladores GABAérgicos/uso terapêutico , Locomoção/efeitos dos fármacos , Masculino , Aprendizagem em Labirinto/efeitos dos fármacos , Midazolam/uso terapêutico , Monoterpenos/farmacologia , Destreza Motora/efeitos dos fármacos , Análise Multivariada , Norepinefrina/sangue , Extratos Vegetais/farmacologia , Ratos , Ratos Sprague-Dawley , Receptores de GABA-A/efeitos dos fármacos
8.
AANA J ; 75(5): 333-7, 2007 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-17966676

RESUMO

The definitive anxiolytic effects of Passiflora incarnata are unknown. We studied the potential anxiolytic effects of chrysin, a Passiflora extract, and the purported modulation of the benzodiazepine receptor on the GABA(A) receptor in laboratory rats. We hypothesized that chrysin decreases anxiety via interaction with the GABA(A) receptor in laboratory rats as measured by elevated plus-maze (EPM), corticosterone, and catecholamine assays. We randomized 44 male Sprague-Dawley rats in a double-blind, placebo-controlled, between-subjects experimental design. Each animal received an intraperitoneal injection of (1) vehicle (DMSO 4%), (2) chrysin, 2 mg/kg, (3) midazolam, 1.5 mg/kg, or (4) flumazenil, 3 mg/kg and chrysin, 2 mg/kg. The EPM was used to evaluate the behavioral component of anxiolysis, and catecholamine and corticosterone assays were examined to measure the neurohormonal effects of anxiety. No statistical difference was found among groups in catecholamine and corticosterone levels. Midazolam significantly decreased anxiety compared with control and flumazenil plus chrysin groups (P <.05); there was no significant difference compared with the chrysin group. These data suggest that chrysin may have anxiolytic properties similar to midazolam but to a lesser magnitude at the 2 mg/kg dose used in this study.


Assuntos
Ansiolíticos/uso terapêutico , Ansiedade/tratamento farmacológico , Flavonoides/uso terapêutico , Passiflora , Extratos Vegetais/uso terapêutico , Análise de Variância , Animais , Ansiolíticos/sangue , Ansiolíticos/farmacologia , Comportamento Animal , Catecolaminas/sangue , Corticosterona/sangue , Dimetil Sulfóxido , Modelos Animais de Doenças , Método Duplo-Cego , Avaliação Pré-Clínica de Medicamentos , Flavonoides/sangue , Flavonoides/farmacologia , Flumazenil/uso terapêutico , Masculino , Aprendizagem em Labirinto/efeitos dos fármacos , Midazolam/uso terapêutico , Fitoterapia/métodos , Distribuição Aleatória , Ratos , Ratos Sprague-Dawley , Receptores de GABA-A/efeitos dos fármacos
9.
Neurosci Res ; 45(3): 305-11, 2003 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-12631466

RESUMO

Cullin-5 (cul-5), a member of the cullin gene family, may have a role in proteolysis and cell cycle regulation. Our recent study demonstrated that cul-5 mRNA is ubiquitously expressed in the central nervous system and many peripheral organs. The present study used quantitative realtime polymerase chain reaction to measure changes in cul-5 mRNA expression as a consequence of osmotic stress in vivo. Cul-5 mRNA levels were significantly increased in the rat cerebral cortex, hypothalamus and kidney following 48 h of water deprivation. Water deprivation for a shorter time period (24 h) or rehydration (24 h access to water following 48 h of water deprivation) also elevated kidney cul-5 mRNA levels. Water deprivation did not significantly alter cul-5 mRNA levels in the brainstem, cerebellum, hippocampus, lung or liver. Since cul-5 appears to be linked to proteosome-mediated protein degradation, it may have a role in protein regulation under conditions of osmotic stress.


Assuntos
Córtex Cerebral/metabolismo , Proteínas Culina , Hipotálamo/metabolismo , Rim/metabolismo , Proteínas de Membrana/biossíntese , RNA Mensageiro/biossíntese , Receptores de Vasopressinas/biossíntese , Equilíbrio Hidroeletrolítico/fisiologia , Animais , Proteínas de Ciclo Celular/biossíntese , Proteínas de Ciclo Celular/genética , Masculino , Proteínas de Membrana/genética , Pressão Osmótica , Ratos , Ratos Long-Evans , Receptores de Vasopressinas/genética , Privação de Água/fisiologia , Equilíbrio Hidroeletrolítico/genética
10.
Neurosci Lett ; 345(2): 121-5, 2003 Jul 17.
Artigo em Inglês | MEDLINE | ID: mdl-12821186

RESUMO

Cullin-5 (Cul-5), an E3 ubiquitin ligase that covalently binds ubiquitin to proteins targeted for degradation via the proteasome, was examined for its localization and distribution in the rat central nervous system (CNS). We showed cul-5 mRNA expression in rat neuronal, glial, and vascular endothelial cells by reverse transcription-polymerase chain reaction and corroborated these data by Cul-5 immunostaining in neurons, astrocytes, blood vessels, and choroid plexus of the laboratory rat. Widespread and ubiquitous expression of Cul-5 in the brain suggests that it may have a vital role(s) in cellular activities of the CNS.


Assuntos
Sistema Nervoso Central/metabolismo , Proteínas Culina , Proteínas de Membrana/metabolismo , Receptores de Vasopressinas/metabolismo , Ubiquitina/metabolismo , Animais , Sistema Nervoso Central/anatomia & histologia , Proteína Glial Fibrilar Ácida/metabolismo , Imuno-Histoquímica/métodos , Proteínas de Membrana/genética , Proteínas Nucleares/metabolismo , RNA Mensageiro/biossíntese , Ratos , Ratos Long-Evans , Receptores de Vasopressinas/genética , Reação em Cadeia da Polimerase Via Transcriptase Reversa/métodos
11.
Neurol Res ; 25(2): 211-6, 2003 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-12635525

RESUMO

Hemorrhagic shock is a clinical syndrome that manifests as hypoperfusion, hypoxia, and ischemia initiating various cellular stress responses involved in the synthesis and release of an assortment of pro-inflammatory molecules, cytokines, chemokines, and reactive oxidant species (ROS). The ROS have been shown to oxidize and damage proteins making them targets for ubiquitination and proteasomal degradation. Cullin-5 (cul-5), an E3 ligase that binds ubiquitin to proteins targeted for degradation via the proteasome, was investigated for its gene expression during hemorrhagic shock. Male Long-Evans rats were subjected to volume controlled (27 ml kg-1) hemorrhage over 10 min and kept in shock for 60 min. Quantitative realtime polymerase chain reaction showed cul-5 mRNA levels were significantly increased in the brainstem and cerebellum, and decreased in the hypothalamus of rats as a result of hemorrhagic shock (n = 6) compared to sham-treated rats (n = 6). Cul-5 mRNA levels in the cerebral cortex, small intestine, kidney, liver, lung, or pituitary gland did not significantly change after hemorrhagic shock. This is the first report of cul-5 mRNA regulation by hemorrhagic shock. Evidence indicates this protein may have a regulatory role in ubiquitin-proteasomal protein degradation in response to hemorrhagic shock.


Assuntos
Encéfalo/fisiologia , Proteínas Culina , Proteínas de Membrana/genética , Proteínas de Membrana/metabolismo , Receptores de Vasopressinas/genética , Receptores de Vasopressinas/metabolismo , Choque Hemorrágico/fisiopatologia , Animais , Cisteína Endopeptidases/metabolismo , Expressão Gênica/fisiologia , Masculino , Complexos Multienzimáticos/metabolismo , Complexo de Endopeptidases do Proteassoma , RNA Mensageiro/análise , Ratos , Ratos Long-Evans , Choque Hemorrágico/metabolismo , Ubiquitina/metabolismo
12.
AANA J ; 70(4): 301-10, 2002 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-12242929

RESUMO

Myasthenia gravis (MG) is the prototypical neurological autoimmune disease. It is characterized by muscle weakness that progressively worsens on repetition but improves with rest. Muscle weakness and fatigability arise from defective or decreased acetylcholine receptors at the neuromuscular junctions, where nerve signals from spinal motor neurons that innervate muscles cannot effectively induce muscle contraction. Several mechanisms of pathogenesis lead to the MG syndrome. The most prevalent cause of MG is an autoimmune disorder in which the patient produces antibodies that attack the nicotinic acetylcholine receptor at the neuromuscular junction. Anesthesia management of the patient with MG is challenging and requires specific management; however, safe and successful outcomes are achievable. This course emphasizes the autoimmune neuromuscular defect in MG, current treatments for this syndrome, contraindications of certain anesthetic drugs in this condition, and anesthetic management of a patient with MG in the operating room environment.


Assuntos
Anestesia/métodos , Miastenia Gravis/etiologia , Miastenia Gravis/imunologia , Enfermeiros Anestesistas , Educação Continuada em Enfermagem , Humanos
SELEÇÃO DE REFERÊNCIAS
Detalhe da pesquisa